NCT05105204

Brief Summary

A continuous noninvasive blood pressure monitoring digital fingertip clip device, the ArteVu, will be compared against the reference arterial catheter during operation. The device safety and its blood pressure accuracy will be examined in the study.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 14, 2021

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

October 4, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 3, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2022

Completed
Last Updated

November 3, 2021

Status Verified

October 1, 2021

Enrollment Period

6 months

First QC Date

October 4, 2021

Last Update Submit

October 22, 2021

Conditions

Keywords

non-invasive blood pressure monitorarterial waveform

Outcome Measures

Primary Outcomes (1)

  • Blood pressure and heart rate measurement accuracy

    To validate ArteVu's blood pressure and heart rate measurement accuracy by comparing its values simultaneously with the corresponding values obtained intra-arterially from an invasive radial arterial line, meeting a bias (as measured by overall mean difference) less than 5 mmHg and a standard deviation less than 8 mmHg for systolic and diastolic blood pressure. This accuracy satisfies the limits established for the validation of automatic blood pressure measurement according to the ANSI/AAMI/ISO 81060-2 standard.

    around two hours.

Study Arms (1)

Individuals need intra-arterial catheter at the radial artery for blood pressure monitoring

Individuals who requiring the use of intra-arterial catheter at the radial artery for continuous blood pressure monitoring for at least two hours as part of their planned care.

Device: ArteVu

Interventions

ArteVuDEVICE

The study participants will concurrently undergo noninvasive blood pressure monitoring with the ArteVu finger clip applied to the same extremity that is being used to measure the radial artery pressure.

Individuals need intra-arterial catheter at the radial artery for blood pressure monitoring

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient enrollment will continue until at least 30% are male; 30% are female; at least 40 % patients have a limb circumference that lies within the upper half of 22-32 cm; at least 40 % are within the lower half of 22-32 cm; in addition, 50 complete one-hour CNBP and NBP data sets are obtained. To assure that a sufficient range of blood pressure values are obtained, at least 10% of the measurements shall have invasive reference systolic blood pressure(SBP) lower or equal to 100 mmHg. At least 10% of the measurements shall have invasive reference SBP higher or equal to 160 mmHg. At least 10% of the measurements shall have invasive reference diastolic blood pressure(DBP) lower or equal to 70mmHg. At least 10% of the measurements shall have invasive reference DBP higher or equal to 85 mmHg.

You may qualify if:

  • Age ≥ 20 years
  • Requiring general anesthesia and continuous blood pressure measurement with a radial arterial line
  • Limb circumference is within 22 cm - 32 cm
  • The width of the first knuckle of the index/middle/Ring finger is less than 19.8 mm
  • Ease of access to the finger and arm used for ArteVu
  • Able to provide written informed consent for participation in the study

You may not qualify if:

  • Pregnant patients
  • Medical or surgical condition that prevents the ability to apply the ArteVu device on an upper extremity finger or the ipsilateral arm such as impaired skin integrity
  • Operations involving the upper extremities or the blood vessels of the upper extremities
  • Arthritis or severe deformities of the hand and fingers
  • Prosthetic devices or jewelry that cannot be removed from the finger or the ipsilateral arm to be used for the ArteVu device
  • History of malignant hyperthermia
  • Raynaud's disease affecting the fingers or hands
  • Topical allergy to Acrylonitrile Butadiene Styrene(ABS), Polycarbonate(PC), or silicone
  • Swelling, edema or lymphedema of the upper extremity
  • Participants with upper extremity occlusive peripheral vascular diseases
  • Inability of the patient to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University Hospital

Taipei, 11031, Taiwan

RECRUITING

Related Publications (9)

  • Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement. N Engl J Med. 2009 Jan 29;360(5):e6. doi: 10.1056/NEJMvcm0800157. No abstract available.

    PMID: 19179309BACKGROUND
  • Stenglova A, Benes J. Continuous Non-Invasive Arterial Pressure Assessment during Surgery to Improve Outcome. Front Med (Lausanne). 2017 Nov 17;4:202. doi: 10.3389/fmed.2017.00202. eCollection 2017.

    PMID: 29204425BACKGROUND
  • Froehler MT, Chitale R, Magarik JA, Fusco MR. Comparison of a pressure-sensing sheath and radial arterial line for intraoperative blood pressure monitoring in neurointerventional procedures. J Neurointerv Surg. 2018 Aug;10(8):784-787. doi: 10.1136/neurintsurg-2018-013769. Epub 2018 Feb 27.

    PMID: 29487193BACKGROUND
  • Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.

    PMID: 2868172BACKGROUND
  • Martina JR, Westerhof BE, van Goudoever J, de Beaumont EM, Truijen J, Kim YS, Immink RV, Jobsis DA, Hollmann MW, Lahpor JR, de Mol BA, van Lieshout JJ. Noninvasive continuous arterial blood pressure monitoring with Nexfin(R). Anesthesiology. 2012 May;116(5):1092-103. doi: 10.1097/ALN.0b013e31824f94ed.

    PMID: 22415387BACKGROUND
  • Gratz I, Deal E, Spitz F, Baruch M, Allen IE, Seaman JE, Pukenas E, Jean S. Continuous Non-invasive finger cuff CareTaker(R) comparable to invasive intra-arterial pressure in patients undergoing major intra-abdominal surgery. BMC Anesthesiol. 2017 Mar 21;17(1):48. doi: 10.1186/s12871-017-0337-z.

    PMID: 28327093BACKGROUND
  • Hohn A, Defosse JM, Becker S, Steffen C, Wappler F, Sakka SG. Non-invasive continuous arterial pressure monitoring with Nexfin does not sufficiently replace invasive measurements in critically ill patients. Br J Anaesth. 2013 Aug;111(2):178-84. doi: 10.1093/bja/aet023. Epub 2013 Mar 13.

    PMID: 23485882BACKGROUND
  • Kim SH, Lilot M, Sidhu KS, Rinehart J, Yu Z, Canales C, Cannesson M. Accuracy and precision of continuous noninvasive arterial pressure monitoring compared with invasive arterial pressure: a systematic review and meta-analysis. Anesthesiology. 2014 May;120(5):1080-97. doi: 10.1097/ALN.0000000000000226.

    PMID: 24637618BACKGROUND
  • Gerlach G, Hofer HW. Interaction of immobilized phosphofructokinase with soluble muscle proteins. Biochim Biophys Acta. 1986 May 2;881(3):398-404. doi: 10.1016/0304-4165(86)90032-2.

Related Links

Study Officials

  • Chuen-Chau Chang, M.D,PhD.

    Taipei Medical University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leng-Chun Chen, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2021

First Posted

November 3, 2021

Study Start

September 14, 2021

Primary Completion

March 1, 2022

Study Completion

June 1, 2022

Last Updated

November 3, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

IPD (study protocol and analytic code) that underlines the results reported in a further publication article, after de-identification.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
The estimated study completion date is 2022-6-30. These supporting information would become available beginning 3 months and ending 5 years following article publication.
Access Criteria
Researches who provide a methodologically sound proposal.

Locations